T1	Participants 95 108	schizophrenia
T2	Participants 294 307	schizophrenia
T3	Participants 473 500	patients with schizophrenia
T4	Participants 502 604	Sixteen schizophrenia patients with predominantly negative symptoms on stable antipsychotic medication
